Dr. Mohammed Ali Alghamdi, MD

Dr. Alghamdi practices at Albany Medical Center in Albany, New York.

Dr. Alghamdi's NPI, 1558713875, was assigned on July 11, 2016. Dr. Alghamdi graduated from King Abdulaziz University College of Medicine in 2014. Dr. Alghamdi's Pennsylvania license number on file is MD478160.

Dr. Alghamdi's primary practice is Albany Medical Center, at 43 New Scotland Ave, Albany, NY 12208 in Albany County. The practice phone is (662) 627-4768.

Dr. Alghamdi's primary practice is Albany Medical Center in Albany, New York. Dr. Alghamdi is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Albany Med EmUrgentCare. Dmand AI also links Dr. Alghamdi to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alghamdi practices. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Alghamdi's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Alghamdi is board certified in pathology - anatomic/pathology - clinical by the American Board of Pathology. Dmand AI has Dr. Alghamdi's licenses on file in 3 states: Pennsylvania, New York and Kentucky.

CMS data shows 538 Medicare services from Dr. Alghamdi across 10 procedure codes in 2024, for 210 Medicare patients. Medicare paid $17,825 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 210 Medicare patients who saw Dr. Alghamdi in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alghamdi's median patient age at 63, with 14% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Alghamdi for performance year 2024, reported as part of a group.

Dmand AI links 12 papers to Dr. Alghamdi, published from 2014 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Biomarkers, Tumor, Carcinoma, Renal Cell and Immunohistochemistry. Dr. Alghamdi has published most often in Cureus. Dr. Alghamdi's most frequent co-authors are Sundus I. Bhatti, Mahmut Akgul and Saleh A. Alqahtani, MD.

CMS Open Payments shows 4 general payments to Dr. Alghamdi from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $90.

Dr. Alghamdi graduated from King Abdulaziz University College of Medicine in 2014.

Dr. Alghamdi is in network with 8 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.